Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Argus® II Retinal Prosthesis System Post-Market Surveillance Study

NCT01490827 is registered in ClinicalTrials.gov with Second Sight Medical Products as lead sponsor.

NCT NCT01490827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01490827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Argus® II Retinal Prosthesis System Post-Market Surveillance Study
Lead sponsor
Second Sight Medical Products
Phase
Observational
Overall status
Terminated
Start date
November 30, 2011
Completion date
March 31, 2020
Enrollment
52 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

outer retinal degeneration, retinitis pigmentosa